4//SEC Filing
Tourangeau Greg 4
Accession 0000950170-25-009815
CIK 0001680581other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:15 PM ET
Size
5.3 KB
Accession
0000950170-25-009815
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-24+76,120→ 76,120 totalExercise: $4.16Exp: 2035-01-23→ Common Stock (76,120 underlying)
Footnotes (1)
- [F1]This option was granted on January 24, 2025 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2025, subject to the reporting person's continued service on each such vesting date.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001916566
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:15 PM ET
- Size
- 5.3 KB